Decoding the skirmish over revised Schedule M
Both, large and mid/small size pharma companies, are vital parts of India’s pharma sector, one serving export markets, the other…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Drug Controller General of India
CORBEVAX gets EUA from Health Ministry as heterologous COVID-19 booster shot for 18 years and above
CORBEVAX is expected to be available as a Booster dose on the CoWIN App in public and private vaccination centres from August 12,…
BDR Pharma signs voluntary licensing agreement with Lilly for baricitinib
Lilly had recently announced seven other voluntary license agreements with major drug manufacturers in India for the production of…
DCGI calls for suggestions from industry to reduce compliance burden
Pharma associations are likely to submit their recommendations by early next month
Covaxin trial participant’s death unrelated to ‘vaccine or placebo’: Bharat Biotech
He was reported to be healthy in follow-up calls post seven days of his dosing and no adverse reaction was observed or reported,…
SEC recommends EUA for Covishield, DCGI nod awaited
The SEC is also looking at the EUA applications of Pfizer and Bharat Biotech
Intas gets DCGI nod for clinical trials of hyperimmune globulin for COVID-19 treatment
It can be an important therapeutic option that can potentially help combat the disease until a vaccine is available, states the…
CDSCO allows import of COVID-19 drugs with less than 60 per cent shelf life
The import of such drugs may be permitted after taking an undertaking from the importers by the port officers of CDSCO that the…
Zydus announces world’s first drug for the treatment of Non-Cirrhotic NASH
Saroglitazar, approved by DCGI becomes the first ever drug anywhere in the world for treatment of Non-Cirrhotic Non-Alcoholic…
AstraZeneca India receives marketing permission for QTERN
Once-daily anti-diabetes treatment for adults with type-2 diabetes, QTERN combines two anti-hyperglycaemic agents with…